<span style="color: #222222;">Pune-based molecular diagnostics company, Mylab Discovery Solutions has launched ‘Compact XL’ – India’s first machine to automate the manual processes of molecular diagnostic tests such as RT-PCR tests for Covid-19.</span><br />” <span style="color: #222222;">&nbsp;</span><br />” <span style="color: #222222;">Compact XL is a compact bench-top machine that will automate lab processes from sample handling to preparing RT-PCR ready tubes. It is a cartridge-based machine and can test multiple samples at the same time. It can be used for a wide range of RNA/DNA-based tests including Covid-19 RT-PCR tests. The machine can take input of various sample types such as plasma, tissue, sputum and swab.</span><br />” <span style="color: #222222;">&nbsp;</span><br />” <span style="color: #222222;">Speaking about the benefits of this 100 per cent indigenously developed machine, Hasmukh Rawal, MD, Mylab Discovery Solutions said that Compact XL is their most ambitious project so far to make India self-reliant in advanced diagnostics. Compact XL will replace the need of 700 sq ft of clean room lab with a 4×3 benchtop machine and reduce the need of 3-4 expert technicians to just one, saving operational costs for labs. From patients’ perspective, automated processes will eliminate errors and improve accuracy, for example, the robotic movements in machine are precise to the tune of hundred-thousandths of a ml when handling liquids. This machine will ensure that DNA/RNA test such as Covid-19 testing can be done without manual error, minimal supervision and reduced human effort. Compact XL will be available for pre-ordering starting from 13th of this month.</span><br />” <span style="color: #222222;">&nbsp;</span><br />” <span style="color: #222222;">Adar Poonawalla, CEO of the Serum Institute of India (SII), who unveiled the machine, said that Scientific and technological breakthroughs are driving our fight against Covid-19. This revolutionary product, with multiple patents already filed, will be a giant leap in making testing accessible. It will eliminate traditional barriers to the adoption of molecular diagnostics at labs and address any potential demand-supply gaps of highly skilled technicians for testing.</span><br />” <span style="color: #222222;">&nbsp;</span><br />” <span style="color: #222222;">Abhijeet Pawar, Chairman, AP Globale, said that an important lesson Covid has taught us, to be self-reliant. He said, their focus is to drive social change through innovation.</span>